Royalty Pharma EVP sells 100K shares at ~$60

Royalty Pharma plc (RPRX) reported insider activity by Christopher Hite, EVP & Chairman, Partnering.

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) reported insider activity by Christopher Hite, EVP & Chairman, Partnering. An entity associated with him, SCH Investment Partners LLC, sold 100,000 Class A Ordinary Shares at a weighted average price of $59.9725 per share pursuant to a Rule 10b5-1 trading plan, leaving 370,401 indirectly held shares. Separately, Hite made a charitable gift of 16,800 Class A Ordinary Shares to Lehigh University, after which he directly held 23,200 shares. Family vehicles also hold exchangeable interests and Class E shares that are convertible into additional Class A Ordinary Shares, some of which are subject to vesting conditions.

Insider Trade Summary 10b5-1

Net Seller: 100,000 shares

Net Sell 2 txns

Insider Hite Christopher

Role EVP & Chairman, Partnering

Sold 100,000 shs ($6.00M)

Type	Security	Shares	Price	Value
Gift	Class A Ordinary Shares F3	16,800	$0.00	$0.00
Sale	Class A Ordinary Shares F1, F2	100,000	$59.9725	$6.00M

Holdings After Transaction: Class A Ordinary Shares — 370,401 shares (Indirect, By SCH Investment Partners LLC); Class A Ordinary Shares — 23,200 shares (Direct)

Footnotes (3)

1. F1. All reported sales were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026.
2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.68 to $60.42 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The Reporting Person made a charitable gift of Class A Ordinary Shares to Lehigh University.

Key Figures

Shares sold by SCH Investment Partners LLC: 100,000 Class A Ordinary Shares Weighted average sale price: $59.9725 per share Indirect holdings after sale: 370,401 Class A Ordinary Shares +4 more

7 metrics

Shares sold by SCH Investment Partners LLC 100,000 Class A Ordinary Shares Non-derivative sale on 2026-08-18 associated with Christopher Hite

Weighted average sale price $59.9725 per share Multiple transactions between $59.68 and $60.42 per share on 2026-08-18

Indirect holdings after sale 370,401 Class A Ordinary Shares Shares held indirectly by SCH Investment Partners LLC following the 2026-08-18 sale

Charitable gift shares 16,800 Class A Ordinary Shares Bona fide gift to Lehigh University on 2026-08-19

Direct holdings after gift 23,200 Class A Ordinary Shares Directly held by Christopher Hite after the 2026-08-19 charitable gift

LP interests exchangeable into Class A 866,410 Class A Ordinary Shares Interests in RPI US Partners 2019, LP held by family vehicles controlled by Hite

Class E shares exchangeable into Class A 1,238,789 Class A Ordinary Shares Class E Ordinary Shares of RPH held by family vehicles, subject to vesting conditions

Key Terms

Rule 10b5-1 plan, bona fide gift, weighted average price, Class E Ordinary Shares

4 terms

Rule 10b5-1 plan regulatory

"All reported sales were effected pursuant to a 10b5-1 plan adopted"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

bona fide gift financial

"transaction_code_description": "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class E Ordinary Shares financial

"Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Christopher Hite report for Royalty Pharma plc (RPRX)?

Christopher Hite reported a sale of 100,000 Class A Ordinary Shares through SCH Investment Partners LLC and a charitable gift of 16,800 shares to Lehigh University, affecting his indirect and direct holdings in RPRX.

How many RPRX shares did SCH Investment Partners LLC sell and at what price?

SCH Investment Partners LLC sold 100,000 Class A Ordinary Shares of RPRX at a weighted average price of $59.9725 per share, with individual trade prices ranging from $59.68 to $60.42 per share.

Were Christopher Hite’s RPRX share sales under a Rule 10b5-1 plan?

Yes. The reported sale of 100,000 RPRX shares by SCH Investment Partners LLC was effected under a Rule 10b5-1 trading plan that Christopher Hite adopted on March 20, 2026, indicating pre-arranged trading instructions.

What charitable gift of Royalty Pharma (RPRX) shares did Christopher Hite make?

Christopher Hite made a charitable gift of 16,800 Class A Ordinary Shares of RPRX to Lehigh University. Following this bona fide gift, his direct holdings in Class A Ordinary Shares totaled 23,200 shares.

What are Christopher Hite’s reported indirect RPRX holdings after the sale?

After the sale, SCH Investment Partners LLC, associated with Christopher Hite, held 370,401 Class A Ordinary Shares of RPRX indirectly. These shares are distinguished from his directly held 23,200 shares reported after the charitable gift.

What additional RPRX-related interests do family vehicles of Christopher Hite hold?

Family vehicles controlled by Christopher Hite hold interests in RPI US Partners 2019, LP exchangeable into 866,410 Class A Ordinary Shares and Class E Ordinary Shares of RPH exchangeable into 1,238,789 Class A Ordinary Shares, with some subject to vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:21 PM Accepted by SEC EDGAR 08/19/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hite Christopher

(Last) (First) (Middle)

C/O ROYALTY PHARMA PLC

110 E. 59TH STREET

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Royalty Pharma plc [ RPRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chairman, Partnering

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Shares	08/18/2026		S(1)		100,000	D	$59.9725(2)	370,401	I	By SCH Investment Partners LLC
Class A Ordinary Shares	08/19/2026		G(3)		16,800	D	$0	23,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. All reported sales were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.68 to $60.42 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person made a charitable gift of Class A Ordinary Shares to Lehigh University.

Remarks:

In addition to the Class A Ordinary Shares disclosed above, family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 866,410 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,238,789 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.

	/s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)